takeaway
improv pbm in-lin retail outlook help
allevi concern around core busi question around
manag care dynam weigh sentiment chang
estim price target
sell season aid extend contract
net sell season loss improv billion billion
result carv smaller piec busi million
exchang medicaid program maintain remain billion
manag throughout
sell season alreadi complet billion pbm
book renew vs billion high retent rate
to-dat includ fep wellcar contract renew estim two
constitut renew to-dat commentari suggest program
new out-of-pocket program diabet care expect save
enrol member averag pocket cost per year
reson client help drive retent diabet program
larg self-fund use save formulari adopt
off-set increment cost
improv purchas econom anoth driver improv pbm outlook
similar commentari earn call
manag discuss gener sourc initi manag red oak
help improv underli cost good off-set reimburs pressur
rebat guarante headwind turn immateri commentari call
suggest work client mitig headwind rebat guarante
track better expect higher client formulari adopt
medic cost trend guidanc /- bp yet show benefit
 distribut unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
base consensu methodolog
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
integr model commentari call suggest cost trend
lower end /- bp guidanc rang suggest
guidanc may conserv compar medic cost guid
cost trend guidanc rais question whether lower cost
trend provid competitor advantag price commerci contract
follow convers manag confirm aetna seen
materi chang marketplac would suggest chang price
commerci enrol trend commerci risk enrol expect
declin year year larg due transit full risk aso
membership lower end small market commerci segment flat
nation account membership ramp anticip
contract win contract small group commerci enrol
govern enrol trend guid membership growth rate
qualit comment point medicar advantag enrol growth
market growth strong growth group
context accord data enrol januari dual
elig special need plan dsnp strategi featur analyst
day progress expand number differ market
still earli stage
oper outlook ahead expect normal prior year
develop net invest gain oper profit segment
expect y/i follow convers manag
suggest adjust oper result benefit prior year
develop portion net invest gain attribut
segment growth would low-double-digit
compani analyst day guidanc high-single-digit
healthhub continu outperform rel legaci store measur script
volum minuteclin visit util health-rel servic began
roll pharmacist panel allow holist view patient data
via integr medic pharmaci data translat
improv medic adher close gap care view posit
care navig help patient navig healthcar system
prefer role provid primari care servic strategi unit
focus though expect may chang time
script growth like benefit share gain expens walgreen
store retail pharmaci script growth outpac market bp
outpac market growth averag bp better trend
like reflect share captur walgreen report bp
headwind script growth lost access medicaid network aetna
busi novemb quarter see context script growth
bp higher walgreen sep -nov store script
growth
earn cadenc estim
line guidanc benefit acceler captur
synergi improv pbm retent sourc off-set rel soft
acceler time synergi quantifi million million
versu million previous increment benefit partial
off-set coupl penni headwind associ impact hif repeal mid-
year renew guidanc includ headwind expect share
dilut option exclud benefit net realiz capit gain
prior year develop benefit
ep lowest year consist manag care peer earn
cadenc factor addit day result leap year typic
retail/pbm season earn ramp year typic
benefit season earn ramp year fourth quarter
weigh increas spend support januari start commentari
in-lin ms street expect quarterli cadenc
respect accordingli
chang estim point
price repres upsid last close price
pt deriv use sotp analysi includ
ev/ebitda multipl retail normal year average ev/ebitda
multipl pharmaci servic express script multipl month prior
acquisit announc price-to-earnings multipl health benefit
in-line w/ average ci multipl rel prior
sell adjust hif repeal
vertic integr enterpris opp transform healthcar deliveri
pt deriv use sotp analysi assign ev/ebitda multipl
retail normal year average ev/ebitda multipl pharmaci servic
express script multipl month prior acquisit announc
price-to-earnings multipl health benet in-line w/ average ci multipl
rel prior sell adjust hif repeal
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
feb gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
combin aetna creat fulli
posit premier player
transform us healthcar
envis pivot role
reshap access health care
leverag exist real estat creat
local healthcar hub lead addit
combin aetna provid path
return earn growth
time align aetna
membership cost synergi
acceler pace debt paydown
de-lever underappreci
view descript risk reward theme
multipl repres peak
multipl compani see
share gain strong sell season
valid integr caremark busi
model health benet assum
price-to-earnings multipl base
premium unitedhealthcar trade
prior medicare-for-al sell
assign ev/ebitda multipl
retail normal year average
ev/ebitda multipl pbm
script multipl month prior
acquisit announc
price-to-earnings multipl in-line average
ci multipl rel
prior sell
adjust hif repeal assum
synergi enterpris
multipl repres trough
multipl initi /caremark
integr period assum
price-to-earnings multipl trough
aetna multipl period structur
prior assum deal synergi
enterpris modern initi
materi also back present
valu estim cash ow associ
potenti opioid payment
front end store sale
retail rx store sale
month premium medic loss ratio
view explan region hierarchi
research highest favor quintil
integr model drive new health plan
amazon ventur
healthcar front end comp improv
growth exce growth seen
plan buy new model
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
